A sensitivity analysis illustrated minor numeric differences31 in the prevalence of Alzheimer pathologic change (A+T−) and biological Alzheimer disease (A+T+) when the analyses were done with different tau PET reporter ROIs compared with the primary tau PET meta-ROI (eTable and eFigure 2 in the Supplement). This evidence concerns the gene MAPT and Alzheimer disease.